Atlas Trials

A Drug-drug Interaction Study of DP-R213

Clinical trial NCT02654093 · COMPLETED

Trial details

NCT number
NCT02654093
Sponsor
Alvogen Korea
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-01-01
Primary completion
2016-03-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.